Clinical Trial: A Study of BL-M08D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07788950) titled 'A Study of BL-M08D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors' on Aug. 24.

Brief Summary: This Phase II study is a clinical trial exploring the efficacy and safety of BL-M08D1 for injection in patients with recurrent or metastatic squamous cell carcinoma of the head and neck and other solid tumors.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Head and Neck Squamous Cell Carcinomas Solid Tumors

Intervention: DRUG: BL-M08D1

Administration by intravenous infusion for a cycle of 3 weeks.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sichuan Bai...